How do I plan the Peoria visit from Surprise?

Where is the nearest clinic?

The nearest verified QC Kinetix location is the Peoria office. The clinic address is 13128 N. 94th Dr., Suite 205, Peoria, AZ 85381. The Plaza del Rio medical campus is near Thunderbird Road and Loop 101. Its non-surgical regenerative treatments are office procedures where a doctor or another licensed medical provider may use spun marrow, washed fat, or platelets separated from your blood.

Bell Road gives many Surprise residents a direct east-west route. Grand Avenue may work better from the Original Town Site. From farther north, Loop 303 can add time before you reach Peoria. When possible, use a road your driver already knows.

Who needs to come with me?

Ask the clinic whether your procedure requires a driver. You may not get medicine that makes you sleepy, yet sitting can still hurt after marrow or fat is removed. Your companion can listen to the wound-care directions and watch for warning signs. After the drive, that person can help you settle in at home.

Confirm the parking and suite entrance before leaving Surprise. Save errands for a different trip. I’d allow extra time near Bell Road and Loop 101 traffic. A quiet evening makes the care directions easier to follow.

What will the visit cost me?

There isn’t a reliable Surprise-wide average in the information used here. Patients often pay for these procedures themselves. Ask for a written price naming the procedure and follow-up. The quote needs to say whether another visit costs more.

Before agreeing, ask what could make the doctor stop a marrow or fat draw, when that decision would happen, and how much you’d owe. Find out whether the visit could end after the exam. Price alone can’t tell you whether the procedure fits. Compare the full bill, recovery time, and reason tied to your joint.

Sources

1. The OARSI non-surgical management guideline evaluated 60 interventions with GRADE methodology and built its recommendations around core treatments - structured exercise, weight management and self-management education - for every patient with knee osteoarthritis, regardless of what else is added.

   Bannuru RR, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

2. In 96 patients, concentrated bone marrow aspirate contained a mean of 26.3 million nucleated cells per mL but only about 1,422 colony-forming units of connective tissue progenitors, and the nucleated cell count had negligible predictive value for how many progenitor cells were actually present (r-squared 0.28).

   Muench LN, et al. — Nucleated Cell Count Has Negligible Predictive Value for the Number of Colony-Forming Units for Connective Tissue Progenitor Cells (Stem Cells) in Bone Marrow Aspirate Harvested From the Proximal Humerus During Arthroscopic Rotator Cuff Repair. Arthroscopy, 2021. DOI: 10.1016/j.arthro.2021.01.064.

3. FDA states in its consumer alert that the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system, and that NONE of these products - stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic fluid - has been approved for the treatment of any orthopedic condition, including osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain or shoulder pain.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. , 2020.

4. In a 480-patient, four-arm, multicenter randomized phase 2/3 trial, none of three orthobiologic cell injections - autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, or allogeneic umbilical cord tissue-derived mesenchymal stromal cells - was superior to any other, or to a corticosteroid injection control, on pain at 12 months.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med, 2023. DOI: 10.1038/s41591-023-02632-w.